Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT04658472 · COMPLETED
Trial details
- NCT number
- NCT04658472
- Sponsor
- Bioverativ, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2025-10-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.